Canary Capital has applied to launch a spot exchange-traded fund (ETF) dedicated exclusively to US-origin tokens. The firm ...

Canary Capital files for an American-made crypto ETF, while Grayscale seeks approval for an Avalanche ETF in the US.

Prominent asset manager Canary Capital filed an S-1 form with the Securities and Exchange Commission (SEC) on Aug. 25, ...

Canary has filed for an American-Made Crypto ETF that will focus on coins hat have ties to the U.S. and may include XRP, SOL, ...

Canary American-Made Crypto ETF joins a long line of funds that give investors exposure to digital assets, as issuers race to meet rising demand with products that track cryptocurrencies, blockchain ...

Canary Capital Group has filed a revised S-1 form with the U.S. SEC for its proposed Canary XRP ETF. This move is viewed as ...

Canary Capital amends S-1 for XRP ETF, raising approval hopes as lawsuit dismissal boosts confidence in Ripple’s regulatory ...

Canary Capital, an investment firm specializing in cryptocurrency ETFs, has made a move hinting at rising institutional ...

ETF inflows and institutional demand are driving Bitcoin’s rise, Canary Capital CEO Steven McClurg said—but he's bearish on ...

Canary Capital’s Paul Hart remains bullish on gold and outlines why he’s chosen these three ASX stocks as potentially winning picks for investors. Gold hit record highs of close to US$2800/oz ...

Canary Capital gives Bio a discounted cash flow valuation of $0.66 a share and an equity valuation of $126.2 million – up from the current market cap of $48.75 million.

Canary Capital’s Paul Hart remains bullish on gold and outlines why he’s chosen these three ASX stocks as potentially winning picks for investors. Gold hit record highs of close to US$2800/oz ...